IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS

IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS

Children with bronchopulmonary dysplasia belong to the risk group of severe respiratory-syncytial viral infection (RSV). World experience and authors' own clinical data show that seasonal immunoprophylaxis of RSV infection's severe course by palivizumab in these patients allows reducing fr...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Baranov, I. V. Davydova, T. V. Turti, L. S. Namazova-Baranova, V. V. Altunin, E. P. Zimina, E. V. Pavlyukova
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2012-12-01
Series:Педиатрическая фармакология
Subjects:
respiratory-syncytial virus
bronchopulmonary dysplasia
acute respiratory viral infection
respiratory function
palivizumab
Online Access:https://www.pedpharma.ru/jour/article/view/268
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Children with bronchopulmonary dysplasia belong to the risk group of severe respiratory-syncytial viral infection (RSV). World experience and authors' own clinical data show that seasonal immunoprophylaxis of RSV infection's severe course by palivizumab in these patients allows reducing frequency of hospitalizations, CPR conduct and fatal outcomes. The article gives data of clinical instrumental evaluation of efficacy and safety of palivizumab use in the 3 past and the 4th (current) epidemic seasons.
ISSN:1727-5776
2500-3089

Similar Items